Transaction and Regulatory Concerns for Women’s Health and Fertility: Five Key Takeaways

The women’s health market continues to see unprecedented competition for transactions, write attorneys with McGuireWoods. These trends, along with COVID-19-specific transaction considerations, create interesting dynamics for investors and providers in the women’s health and fertility subsectors, as discussed during a webinar, “Key Transaction and Regulatory Considerations for Women’s Health and Fertility,” presented by McGuireWoods healthcare lawyers Kayla Marty and Erin Dine. Read more.

Total
0
Shares
Related Posts